Charles D. Nichols

A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain.

Yan regulates Lozenge during Drosophila eye development.

Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration.

Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase-1, C/EBP-beta and ILAD-1, a novel gene with homology to arrestins.

Alternative splicing removes an Ets interaction domain from Lozenge during Drosophila eye development.

Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery.

5-HT2 receptors in Drosophila are expressed in the brain and modulate aspects of circadian behaviors.

Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.

Serotonin receptors.

Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency.

Anterograde trafficking of G protein-coupled receptors: function of the C-terminal F(X)6LL motif in export from the endoplasmic reticulum.

Engineered G-protein Coupled Receptors are Powerful Tools to Investigate Biological Processes and Behaviors.

Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases.

An animal model of schizophrenia based on chronic LSD administration: old idea, new results.

Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.

The serotonin 5-HT7Dro receptor is expressed in the brain of Drosophila, and is essential for normal courtship and mating.

Insulin-producing cells in the brain of adult Drosophila are regulated by the serotonin 5-HT1A receptor.